The Foundation is excited to announce today the creation of the Giovanis Institute for Translational Cell Biology, with a $35 million gift from researcher, philanthropist and race car driver Ted Giovanis.
The Institute will enable scientists at Johns Hopkins Medicine to study the biological roots of the most fatal aspect of cancer: how it metastasizes or spreads through the body.
The contribution is a 15-year commitment and the Institute’s researchers aim to make discoveries that reveal common features of metastasis across cancer types, with the potential to develop new therapies.
Read the full announcement from Johns Hopkins Medicine here.
Featured news
Ted’s Take: It’s about the money
Money is what seems to drive things and money is what seems to drive organizations too. They all start with an overriding moral goal but after a while things often turn toward more money.
Ted’s Take: The best patient advocate? You.
When you’re a patient, you are kind of vulnerable. You have a problem, are often sketchy about what it is and the potential treatment or therapy needed. The bigger the problem, the more vulnerable you are. This makes you a perfect advocate.
Targeting effective treatments for triple-negative breast cancer
The JKTG Foundation recently awarded funding to Laura Heiser, Ph.D., Associate Professor and Vice Chair of Biomedical Engineering at the Oregon Health & Science University (OHSU) School of Medicine, to develop a prototype multiscale model designed to predict therapeutic responses of tumor ecosystems – a new frontier in breast cancer research.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133